C. Puertolas, J. Puertolas
Energy for Health [25], 2026
Background: Avulsion fractures of the ischial tuberosity are uncommon injuries in pediatric athletes that can significantly impair function. Conservative management is generally preferred when displacement is limited, but return to sport often requires several months.
Case presentation: We describe a 12-year-old male athlete who sustained an acute avulsion fracture of the right ischial tuberosity during an Australian Rules Football match. Initial management included protected weight-bearing and suspension from sports. Upon parental request, adjunctive photobiomodulation therapy (PBMT) was initiated using the MLS® Robotic M8 laser system. The seven-week protocol involved simultaneous treatment of the avulsion site and proximal hamstring with tailored parameters delivered by a handheld applicator and a robotic scanning head. MRI at week six demonstrated reattachment of the fragment with bridging callus formation and resolution of surrounding edema. Clinically, the patient had discontinued crutches, started jogging, and by week seven had returned to full participation in both soccer and AFL without pain or functional limitations. No adverse effects or physiotherapy were required, and surgery was definitively avoided.
Conclusion: This is, to our knowledge, the first documented case of a pediatric ischial tuberosity avulsion fracture managed with adjunctive PBMT. The therapy was well tolerated and associated with accelerated clinical and radiological recovery, enabling full return to sport in less than two months. These findings suggest that PBMT may be a safe and valuable adjunct to conservative management of apophyseal avulsions in young athletes, warranting further clinical investigation. Further controlled studies are needed to validate these findings and explore their applicability in pediatric sports medicine
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.